Versant Venture Capital VI L.P. insider trades
Open-market stock purchases and sales by Versant Venture Capital VI L.P., Unknown at LENZ Therapeutics, Inc, from SEC Form 4 filings since Jun 24, 2019.
Track record: 13% of 8 scored buys are up 5% or more since purchase, averaging -36%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- LENZ LENZ Therapeutics, Inc: 34 sales, last Sep 30, 2025
- LVTX LAVA Therapeutics NV: 8 sales, last Sep 19, 2025
- GLUE Monte Rosa Therapeutics, Inc: 1 buy, 7 sales, last Oct 29, 2024
- BDTX Black Diamond Therapeutics, Inc: 4 buys, 67 sales, last Aug 28, 2024
- TPST Tempest Therapeutics, Inc: 2 sales, last Aug 12, 2024
- CTNM Contineum Therapeutics, Inc: other filings, last Apr 9, 2024
- OYST Oyster Point Pharma, Inc: 3 buys, 4 sales, last Jan 3, 2023
- IPSC Century Therapeutics, Inc: 1 buy, 1 sale, last Aug 9, 2022
- GRPH Graphite Bio, Inc: 1 buy, last Jun 29, 2021
- ALGS Aligos Therapeutics, Inc: 1 buy, last Oct 20, 2020
- PAND Pandion Therapeutics, Inc: other filings, last Jul 21, 2020
- PASG Passage BIO, Inc: 1 buy, last Mar 3, 2020
Get free alerts when Versant Venture Capital VI L.P. files a new trade →